Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Opal L Reddy

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Diagnostic Pathology|June 19, 2017
Programmed death-ligand 1 (PD-L1) is expressed in a significant number of the uterine cervical carcinomasOpal L Reddy, Peter I Shintaku, Neda A Moatamed
Seminars in Hematology|September 7, 2020
Improving CAR T cell therapy by optimizing critical quality attributesOpal L Reddy, David F Stroncek, Sandhya R Panch
Seminars in Hematology|September 7, 2020
Advances in gene therapy for hematologic disease and considerations for transfusion medicineOpal L Reddy, Bipin N Savani, David F Stroncek, et al.
Archives of Pathology & Laboratory Medicine|June 24, 2017
Application of Immunohistochemistry in the Diagnosis of Pulmonary and Pleural NeoplasmsJennifer S Woo, Opal L Reddy, Matthew Koo, et al.
Transfusion|April 3, 2025
Hospitalizations with blood transfusions and transfusion-related adverse events in US acute care hospitals, 2016-2020Sophia V Kazakova, Opal L Reddy, Isabel Griffin, et al.
Transfusion|March 28, 2023
Effects of extended transport on cryopreserved allogeneic hematopoietic progenitor cell (HPC) product quality and optimal methods to assess HPC stabilityOpal L Reddy, Mame Thioye Sall, Anh Dinh, et al.
Clinical Hematology International|October 1, 2021
Robust Selections of Various Hematopoietic Cell Fractions on the CliniMACS Plus InstrumentSandhya R Panch, Opal L Reddy, Katherine Li, et al.
Journal of Translational Medicine|December 12, 2022
Longitudinal transcriptional analysis of peripheral blood leukocytes in COVID-19 convalescent donorsMallikarjuna R Gedda, Patrick Danaher, Lipei Shao, et al.
The American Journal of Pathology|April 25, 2015
Loss of FOXA1 Drives Sexually Dimorphic Changes in Urothelial Differentiation and Is an Independent Predictor of Poor Prognosis in Bladder CancerOpal L Reddy, Justin M Cates, Lan L Gellert, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Diagnostic Pathology|June 19, 2017
Programmed death-ligand 1 (PD-L1) is expressed in a significant number of the uterine cervical carcinomasOpal L Reddy, Peter I Shintaku, Neda A Moatamed
Seminars in Hematology|September 7, 2020
Improving CAR T cell therapy by optimizing critical quality attributesOpal L Reddy, David F Stroncek, Sandhya R Panch
Seminars in Hematology|September 7, 2020
Advances in gene therapy for hematologic disease and considerations for transfusion medicineOpal L Reddy, Bipin N Savani, David F Stroncek, et al.
Archives of Pathology & Laboratory Medicine|June 24, 2017
Application of Immunohistochemistry in the Diagnosis of Pulmonary and Pleural NeoplasmsJennifer S Woo, Opal L Reddy, Matthew Koo, et al.
Transfusion|April 3, 2025
Hospitalizations with blood transfusions and transfusion-related adverse events in US acute care hospitals, 2016-2020Sophia V Kazakova, Opal L Reddy, Isabel Griffin, et al.
Transfusion|March 28, 2023
Effects of extended transport on cryopreserved allogeneic hematopoietic progenitor cell (HPC) product quality and optimal methods to assess HPC stabilityOpal L Reddy, Mame Thioye Sall, Anh Dinh, et al.
Clinical Hematology International|October 1, 2021
Robust Selections of Various Hematopoietic Cell Fractions on the CliniMACS Plus InstrumentSandhya R Panch, Opal L Reddy, Katherine Li, et al.
Journal of Translational Medicine|December 12, 2022
Longitudinal transcriptional analysis of peripheral blood leukocytes in COVID-19 convalescent donorsMallikarjuna R Gedda, Patrick Danaher, Lipei Shao, et al.
The American Journal of Pathology|April 25, 2015
Loss of FOXA1 Drives Sexually Dimorphic Changes in Urothelial Differentiation and Is an Independent Predictor of Poor Prognosis in Bladder CancerOpal L Reddy, Justin M Cates, Lan L Gellert, et al.
Pageof 1